CBER Pledges To Create Standards Boosting WNV Screening Development
This article was originally published in The Gray Sheet
Executive Summary
FDA's Center for Biologics Evaluation & Research will establish performance criteria and standards to facilitate the development of nucleic acid tests (NAT) to screen donated blood for the West Nile virus